Cargando…
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis
Autores principales: | Ielapi, Nicola, Licastro, Noemi, Provenzano, Michele, Andreucci, Michele, de Franciscis, Stefano, Serra, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236792/ https://www.ncbi.nlm.nih.gov/pubmed/32426991 http://dx.doi.org/10.2217/bmm-2020-0201 |
Ejemplares similares
-
The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients
por: Provenzano, Michele, et al.
Publicado: (2020) -
Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020) -
The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?
por: Provenzano, Michele, et al.
Publicado: (2020) -
Roles and Clinical Applications of Biomarkers in Cardiovascular Disease
por: de Franciscis, Stefano, et al.
Publicado: (2016) -
Roles and Clinical Applications of Biomarkers in Cardiovascular Disease 2017
por: Serra, Raffaele, et al.
Publicado: (2017)